Peter Barton Hutt Concert Pharmaceuticals, Inc. (CNCE) insider trading activity

Peter Barton Hutt is Director of CONCERT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CNCE, which is worth approximately $0. The most recent transaction as insider was on Mar 06, 2023, when has been sold 13,088 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

PETER BARTON HUTT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	13,088 Reduced 100.0%	0 Common Stock
Mar 06 2023	SELL Sale (or disposition) back to the issuer	-	16,400 Reduced 100.0%	0 Common Stock
Oct 14 2022	SELL Open market or private sale	$21,553 $6.09 p/Share	3,539 Reduced 10.72%	29,488 Common Stock
Oct 14 2022	BUY Exercise of conversion of derivative security	$10,192 $2.88 p/Share	3,539 Added 9.68%	33,027 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	16,400 Added 35.74%	29,488 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	-	5,125 Added 28.14%	13,088 Common Stock

Also insider at

MRNA

Moderna, Inc. Healthcare

Director

IMMU

IMMUNOMEDICS INC

Director

PBH